Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 198

1.

Human marrow-derived mesenchymal stromal cells decrease cisplatin renotoxicity in vitro and in vivo and enhance survival of mice post-intraperitoneal injection.

Eliopoulos N, Zhao J, Bouchentouf M, Forner K, Birman E, Yuan S, Boivin MN, Martineau D.

Am J Physiol Renal Physiol. 2010 Dec;299(6):F1288-98. doi: 10.1152/ajprenal.00671.2009. Epub 2010 Sep 15.

2.

Erythropoietin gene-enhanced marrow mesenchymal stromal cells decrease cisplatin-induced kidney injury and improve survival of allogeneic mice.

Eliopoulos N, Zhao J, Forner K, Birman E, Young YK, Bouchentouf M.

Mol Ther. 2011 Nov;19(11):2072-83. doi: 10.1038/mt.2011.162. Epub 2011 Aug 16.

3.

Bone marrow-derived mesenchymal stem cells protect against cisplatin-induced acute kidney injury in rats by inhibiting cell apoptosis.

Qi S, Wu D.

Int J Mol Med. 2013 Dec;32(6):1262-72. doi: 10.3892/ijmm.2013.1517. Epub 2013 Oct 8.

4.

Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury.

Morigi M, Rota C, Montemurro T, Montelatici E, Lo Cicero V, Imberti B, Abbate M, Zoja C, Cassis P, Longaretti L, Rebulla P, Introna M, Capelli C, Benigni A, Remuzzi G, Lazzari L.

Stem Cells. 2010 Mar 31;28(3):513-22. doi: 10.1002/stem.293.

5.

Stromal cells protect against acute tubular injury via an endocrine effect.

Bi B, Schmitt R, Israilova M, Nishio H, Cantley LG.

J Am Soc Nephrol. 2007 Sep;18(9):2486-96. Epub 2007 Jul 26.

6.

Human adipose tissue-derived mesenchymal stem cells protect kidneys from cisplatin nephrotoxicity in rats.

Kim JH, Park DJ, Yun JC, Jung MH, Yeo HD, Kim HJ, Kim DW, Yang JI, Lee GW, Jeong SH, Roh GS, Chang SH.

Am J Physiol Renal Physiol. 2012 May 1;302(9):F1141-50. doi: 10.1152/ajprenal.00060.2011. Epub 2011 Dec 28.

7.

Renoprotective effect of human umbilical cord-derived mesenchymal stem cells in immunodeficient mice suffering from acute kidney injury.

Fang TC, Pang CY, Chiu SC, Ding DC, Tsai RK.

PLoS One. 2012;7(9):e46504. doi: 10.1371/journal.pone.0046504. Epub 2012 Sep 27.

8.

Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury.

Bruno S, Grange C, Collino F, Deregibus MC, Cantaluppi V, Biancone L, Tetta C, Camussi G.

PLoS One. 2012;7(3):e33115. doi: 10.1371/journal.pone.0033115. Epub 2012 Mar 14.

9.

Mesenchymal-like progenitors derived from human embryonic stem cells promote recovery from acute kidney injury via paracrine actions.

Luo J, Zhao X, Tan Z, Su Z, Meng F, Zhang M.

Cytotherapy. 2013 Jun;15(6):649-62. doi: 10.1016/j.jcyt.2013.01.009. Epub 2013 Feb 14.

PMID:
23415919
10.

Erythropoietin expands a stromal cell population that can mediate renoprotection.

Bi B, Guo J, Marlier A, Lin SR, Cantley LG.

Am J Physiol Renal Physiol. 2008 Oct;295(4):F1017-22. doi: 10.1152/ajprenal.90218.2008. Epub 2008 Jul 23.

11.

VEGF-modified human embryonic mesenchymal stem cell implantation enhances protection against cisplatin-induced acute kidney injury.

Yuan L, Wu MJ, Sun HY, Xiong J, Zhang Y, Liu CY, Fu LL, Liu DM, Liu HQ, Mei CL.

Am J Physiol Renal Physiol. 2011 Jan;300(1):F207-18. doi: 10.1152/ajprenal.00073.2010. Epub 2010 Oct 13.

12.

Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential.

di Bonzo LV, Ferrero I, Cravanzola C, Mareschi K, Rustichell D, Novo E, Sanavio F, Cannito S, Zamara E, Bertero M, Davit A, Francica S, Novelli F, Colombatto S, Fagioli F, Parola M.

Gut. 2008 Feb;57(2):223-31. Epub 2007 Jul 16.

PMID:
17639088
13.

Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice.

Morigi M, Introna M, Imberti B, Corna D, Abbate M, Rota C, Rottoli D, Benigni A, Perico N, Zoja C, Rambaldi A, Remuzzi A, Remuzzi G.

Stem Cells. 2008 Aug;26(8):2075-82. doi: 10.1634/stemcells.2007-0795. Epub 2008 May 22.

14.

The cultivation of human multipotent mesenchymal stromal cells in clinical grade medium for bone tissue engineering.

Pytlík R, Stehlík D, Soukup T, Kalbácová M, Rypácek F, Trc T, Mulinková K, Michnová P, Kideryová L, Zivný J, Klener P Jr, Veselá R, Trnený M, Klener P.

Biomaterials. 2009 Jul;30(20):3415-27. doi: 10.1016/j.biomaterials.2009.03.001. Epub 2009 Apr 10.

PMID:
19362364
15.

Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro.

Zhou Y, Xu H, Xu W, Wang B, Wu H, Tao Y, Zhang B, Wang M, Mao F, Yan Y, Gao S, Gu H, Zhu W, Qian H.

Stem Cell Res Ther. 2013 Apr 25;4(2):34. doi: 10.1186/scrt194.

16.

Purinergic stimulation of human mesenchymal stem cells potentiates their chemotactic response to CXCL12 and increases the homing capacity and production of proinflammatory cytokines.

Ferrari D, Gulinelli S, Salvestrini V, Lucchetti G, Zini R, Manfredini R, Caione L, Piacibello W, Ciciarello M, Rossi L, Idzko M, Ferrari S, Di Virgilio F, Lemoli RM.

Exp Hematol. 2011 Mar;39(3):360-74, 374.e1-5. doi: 10.1016/j.exphem.2010.12.001. Epub 2010 Dec 9.

PMID:
21145936
17.

[Age-related biological characteristics of human bone marrow mesenchymal stem cells from different age donors].

Huang K, Zhou DH, Huang SL, Liang SH.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Dec;13(6):1049-53. Chinese.

PMID:
16403278
18.
19.

Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution after irradiation damage.

François S, Bensidhoum M, Mouiseddine M, Mazurier C, Allenet B, Semont A, Frick J, Saché A, Bouchet S, Thierry D, Gourmelon P, Gorin NC, Chapel A.

Stem Cells. 2006 Apr;24(4):1020-9. Epub 2005 Dec 8.

20.

Transplantation of bone marrow-derived MSCs improves cisplatinum-induced renal injury through paracrine mechanisms.

Cheng K, Rai P, Plagov A, Lan X, Kumar D, Salhan D, Rehman S, Malhotra A, Bhargava K, Palestro CJ, Gupta S, Singhal PC.

Exp Mol Pathol. 2013 Jun;94(3):466-73. doi: 10.1016/j.yexmp.2013.03.002. Epub 2013 Mar 25.

Items per page

Supplemental Content

Write to the Help Desk